Ro60-0175 is a drug developed by Hoffmann–La Roche which has applications in scientific research. It acts as a potent and selective agonist for both the 5-HT2B and 5-HT2C serotonin receptor subtypes with good selectivity over the closely related 5-HT2A subtype and little or no affinity at other receptors.
This page contains content from the copyrighted Wikipedia article "Ro60-0175"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
